Second Trimester Medical Abortion Study Training in Uzbekistan

On August 26, Gynuity conducted a training for the clinical study titled “Mifepristone and misoprostol for mid-trimester termination of pregnancy (13-22 weeks LMP) in Uzbekistan”. The training was held in the capital city Tashkent. The study team consists of twelve obstetricians/gynecologists and six nurses from the following sites: Clinic No. 2 of the Tashkent Medical Academy, Samarkand Perinatal Center, and Bukhara Maternity Hospital No. 1. The Chief of the Maternal and Child Health Department of the Ministry of Health opened the training session and welcomed the study team and the Gynuity trainers. Women’s Wellness Center will be the coordinating partner for this clinical study.